I have 30 years of experience and specialize in the field of cardiology, with specific knowledge of antiarrhythmic drugs, novel therapeutic targets and drug proarrhythmia. I have published on such topics as atrial fibrillation, novel therapeutic targets and cardiac remodeling. I have testified on drug induced long QT syndrome and drug effects on the electrocardiography (ECG).